DermaZinc™

Dermalogix Partners, Inc. is committed to: Providing the fastest acting, longest lasting symptomatic treatments available for chronic skin conditions; Delivering total treatment for skin disorders; and Advancing the frontiers of symptomatic skin disease treatment.
Providing topical treatments that do not affect T cells. Dermalogix Partners donates a portion of its sales to chronic skin disorder research. To Achieve Maximum Results Dermalogix In Conjunction With Our Medical Staff Strongly Recommends Patients Begin Their Treatments By Starting With Our Prescription Strength Formula.
Micronized Betamethasone Dipropionate
Introducing! DermaZinc Compounded with Micronized Betamethasone Dipropionate for the treatment of severe skin conditions. Due to our licensing agreement with Galderma & Clobex Spray Dermalogix Partners, Inc now recommends using DermaZinc products Compounded with Micronized Betamethasone Dipropionate. In connection with our research department we have developed this New Advanced Formulation, which has shown great success. (Betamethasone study) DermaZinc products Compounded with Micronized Betamethasone Dipropionate for the treatment of severe skin conditions.
Dermalogix Partners P.O. Box 1510 Scarborough, ME 04074. Call: 1-800-753-0047 Fax: 1-207-883-8590

Shopping Cart

0 items

No part of this website may be reproduced in any way without the written permission of Dermalogix Partners, Inc.™
All images and graphics are property of Dermalogix Partners, Inc.™
All rights reserved©